Biblio
Found 230 results
Author Keyword Title Type [ Year] Filters: First Letter Of Last Name is K [Clear All Filters]
“Genetic risk for schizophrenia and psychosis in Alzheimer disease.”, Mol Psychiatry, vol. 23, no. 4, pp. 963-972, 2018.
, “Genetic risk for schizophrenia and psychosis in Alzheimer disease.”, Mol Psychiatry, vol. 23, no. 4, pp. 963-972, 2018.
, “Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure.”, Genome Med, vol. 10, no. 1, p. 43, 2018.
, “Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.”, Dement Geriatr Cogn Disord, vol. 45, no. 1-2, pp. 1-17, 2018.
, “Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.”, Dement Geriatr Cogn Disord, vol. 45, no. 1-2, pp. 1-17, 2018.
, “Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.”, PLoS Med, vol. 15, no. 1, p. e1002487, 2018.
, “Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.”, PLoS Med, vol. 15, no. 1, p. e1002487, 2018.
, “Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.”, PLoS Med, vol. 15, no. 1, p. e1002487, 2018.
, “The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease.”, Sci Data, vol. 5, p. 180185, 2018.
, “Quality control and integration of genotypes from two calling pipelines for whole genome sequence data in the Alzheimer's disease sequencing project.”, Genomics, 2018.
, “Quality control and integration of genotypes from two calling pipelines for whole genome sequence data in the Alzheimer's disease sequencing project.”, Genomics, 2018.
, “Quality control and integration of genotypes from two calling pipelines for whole genome sequence data in the Alzheimer's disease sequencing project.”, Genomics, 2018.
, “Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.”, Mol Psychiatry, 2018.
, “Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.”, Mol Psychiatry, 2018.
, “Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.”, Mol Psychiatry, 2018.
, “Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.”, Mol Psychiatry, 2018.
, “Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.”, Mol Psychiatry, 2018.
, “Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease.”, Ann Clin Transl Neurol, vol. 5, no. 7, pp. 832-842, 2018.
, “The Alzheimer's Disease Sequencing Project: Study design and sample selection.”, Neurol Genet, vol. 3, no. 5, p. e194, 2017.
, “Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.”, PLoS Genet, vol. 13, no. 11, p. e1007045, 2017.
, “A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.”, Nat Neurosci, vol. 20, no. 8, pp. 1052-1061, 2017.
, “A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.”, Nat Neurosci, vol. 20, no. 8, pp. 1052-1061, 2017.
, “Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.”, PLoS Med, vol. 14, no. 3, p. e1002258, 2017.
, “Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.”, PLoS Med, vol. 14, no. 3, p. e1002258, 2017.
, “Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.”, PLoS Med, vol. 14, no. 3, p. e1002258, 2017.
,